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Abstract
DNA transposons are mobile elements with the ability to mobilize and transport genetic information between different
chromosomal loci. Unfortunately, most transposons copies are currently inactivated, little is known about mariner
elements in humans despite their role in the evolution of the human genome, even though the Hsmar2 transposon is
associated to hotspots for homologous recombination involved in human genetic disorders as Charcot–Marie–Tooth,
Prader-Willi/Angelman, and Williams syndromes. This manuscript describes the functional characterization of the
human HSMAR2 transposase generated from fossil sequences and shows that the native HSMAR2 is active in
human cells, but also in bacteria, with an efficiency similar to other mariner elements. We observe that the sub-
cellular localization of HSMAR2 is dependent on the host cell type, and is cytotoxic when overexpressed in HeLa
cells. Finally, we also demonstrate that the binding of HSMAR2 to its own ITRs is specific, and that the excision
reaction leaves non-canonical footprints both in bacteria and eukaryotic cells.
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Introduction
Transposons are small mobile genetic elements widely
distributed in the genomes of bacteria, plants, invertebrates
and vertebrates, that have the ability to migrate and carry
genetic material between chromosomal loci [1]. Transposons
have played an important role in the evolution of genes,
including humans, where at least 50 genes derive from
transposable elements [2,3]. In the human genome, DNA
transposons make up to 3% of the genome [2], with nine of the
ten eukaryotic superfamílies present, and ranging from
hundreds to several thousand copies per family [4], specially
the Tc1/mariner superfamily which accounts for one forth of all
the copies.
Transposons of the Tc1/mariner superfamily are widely
distributed in both invertebrate and vertebrate species.
However, due to functional inactivation by mutations
accumulated during evolution no DNA transposon is active in
mammals and are very few in vertebrates [5]. Two mariner
transposons are present in the human genome, Hsmar1 and
Hsmar2, and are associated with the cecropia and irritans
subfamilies respectively. Oosumi and collaborators discovered
Hsmar2 within an inverted repeat structure initially named
Humar1 [6]. By increasing the number of sequences available
in public gene databases, a consensus sequence Hsmar2 was
built using 16 sequences selected from the 1000 copies
already described in the genome [7]. It has been noted that
copies of individual Hsmar2 are highly mutated with respect to
the consensus sequence, with numerous indels as well as stop
codons in the transposase pseudogene, leaving intact only
3.7% of the hypermutable CpG dinucleotides [7]. The low
frequency of CpG suggests that Hsmar2 evolved in the
genome of vertebrates, mutating into CA, TG or derivatives.
This pattern of molecular evolution fits the current model of
neutral evolution for the mariner transposons in the human
genome starting in a common ancestor of the initial suborders
of primates [8]. Although copies of Hsmar2 seem to be the
remnants of an inactive functional mariner element of the
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primate lineage, the analysis of hotspot for homologous
recombination in the human genome has revealed the
presence of Hsmar2 copies near the hotspot for homologous
recombination in, the PWS/AS region (15q13), the WAS region
(7q11), and the CMT1A region (17p12), where large deletions,
or repeated sequences are involved in the molecular
mechanism of genetic disorders as Prader-Willi and Angelman
syndromes (PWS/AS) [9], Williams syndrome (WAS) [10], and
Charcot–Marie–Tooth [11] respectively. Thus, studies of
homologous recombination at the Charcot–Marie–Tooth
disease type 1A suggest that the presence of an Hsmar2
element within two flanking 24-kb repeats (CMT1AREP) may
stimulate unequal crossing-over events between misaligned
CMT1A-REP elements [11,12]. These unequal crossing-over
events can be resolved as either a 1.5-Mb duplication resulting
in Charcot–Marie–Tooth disease or a 1.5-Mb deletion resulting
in hereditary neuropathy with liability to pressure palsies
[13,14]. Moreover, it has been described that of the 109 copies
of Hsmar2 identified by PRINS [15], about 50% of them were in
known fragile sites, suggesting that there may be a potential
correlation between the localization of Hsmar2 copies and
fragile sites in the human genome.
To study the function and activity of DNA transposons, and
considering the absence of any endogenous active copy in the
genomes of mammals, several research groups have
reactivated inactive Tc1/mariner transposons using approaches
based on phylogenetic comparisons. For example, the human
mariner transposon Hsmar1, inserted into the SETMAR gene
by an event of "molecular domestication'' has been revived
using a sequence derived from ancient inactive copies [16]. For
Tc1 transposons, both Sleeping Beauty (SB) [17] and the Frog
Prince elements [18] have been reconstructed from inactive
elements of a salmonid genome and the frog Rana pipiens
genome, respectively. Due to their ability to move around the
genome, transposons have great potential as genetic tools,
and thus most of these elements have been mutated to
hyperactivate their transposase activity in order to apply them
in genetic strategies such as insertional mutagenesis studies,
transpositional transgenesis, or gene therapy strategies in pre-
clinical models [19,20].
In this study, we have characterized an active human
HSMAR2 transposase generated from inactive Tc1/mariner
elements found in the human genome. We show that the
overexpression of HSMAR2 is toxic, but this effect is lost when
using a negative self-regulated expression cassette. We have
also characterized its activity and analyzed each of the
successive steps of the transposition process including binding,
excision and transposition.
Materials and Methods
Reassembling of the Hsmar2 transposon
More than 400 copies of Hsmar2 present in the database
GenEmbl were initially selected using the ITR (Inverted
Terminal Repeats) sequences as probes. After eliminating
repeated copies and short sequences with less than 600
nucleotides of homology, 71 sequences with at least one ITR
were finally chosen. The mínimum and maximum level of
sequence depth was 16 and 41 respectively, and the sequence
obtained (Hsmar2) was based on majority rule for the
alignment. CG dinucleotides were reintroduced in TG or CA
dinucleotides with intermediate frequencies because they likely
derive from changes in the hipermutable CG dinucleotide
during the evolutionary process.
Cell culture, transfection and adenovirus production
HeLa (ATCC, CCL-2), and HEK-293 (ATCC, CRL-1573) are
cell lines of human origin; and C2C12 (ATCC, CRL-1772), S16
(ATCC, CRL-2941), COS-7 (ATCC, CRL-1651) and DKZeo
[21] are of murine, rat, simian and canine origin respectively.
All cell lines were cultured in DMEM + 10% (v/v) FBS, at 37°C
and 5% CO2. Transfection were performed in 60-70% confluent
cultures with DMEM + 1% (v/v) FBS, using 6 µg of DNA
complexed with PEI-25 KDa (Aldrich) per 106 cells, as
previously described [22]. Neomycin and Zeocin selection was
performed using 700 µg/mL of Neomycin or 100 µg/mL of
Zeocin. Briefly, media was replaced every three days until
individual clones were observed (usually in two weeks). Clones
were selected, grown individually and subsequently passaged
until 20x106 cells per clone were obtained. Adenovirus vectors
were generated, amplified and purified as described before
[22].
Analysis of Hsmar2 expression by Western blot
AbHsmar2-1001, a rabbit polyclonal (protein-A purified)
generated in this work was used at a dilution of 1/5000;
polyclonal anti-GFP antibody (Invitrogen, A6455) at a dilution of
1/3000; polyclonal antibody anti-actin (Sigma, A2066) at
1/1000; and secondary polyclonal antibody rabbit HRP-anti-Ig
(Dako-Cytomation, P0399) at 1/5000. Protein extracts (4-12 µg
per sample) were loaded onto denaturing acrylamide gels and
further electrotransferred to PDVF membranes (Amersham).
Primary antibodies were incubated in the presence of 5% (w/v)
skim milk.
Immunoprecipitation
HeLa cells (2x108 cells) were transfected with 70 µg of
pGFP-HSMAR2. Forty-eight hours later, proteins were
extracted. One microgram of antibody AbHsmar2-1001 was
incubated with 300-500 g of protein extracts, for 2 hours at 4°C
with gentle agitation. Immunoprecipitation with protein G
sepharose (Sigma) was performed following manufacture’s
instructions.
Flow cytometry
HEK293 or HeLa cells (1x106 cells) were transfected in
triplicate with increasing amounts of peGFP-HSMAR2 or pKS-
RSV/GFP. Irrelevant plasmid p123T (MoBiTec) was added to
achieve 2.5 µg (HEK293) and 10 µg (HeLa) of total DNA per
condition. At 24, 48, 72 hours cells were harvested and
resuspended in 200 µl PBS1X and propidium iodide (0.4 µg)
for 15 minutes at 4 °C and further analyzed with Flux
FACSCalibur (BD) and Cellquest Software.
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Electrophoretic Mobility Shift Assays (EMSA)
EMSA was performed using biotin-labeled oligonucleotides
from the 5’-ITR. Oligonucleotides sequences are: TR_Dir (5’-
ttaataaaTACGAGGGGTCTTCAAAAAGTTCATGGAAAATGtata
tattaa-3’) and TR_Rev (5’-
ttaatatataCATTTTCCATGAACTTTTTGAAGACCCCTCGTAttta
ttaa-3’). DNA-binding reaction mixtures (20 µl) contained 1nM
of labeled duplex substrate, 1µg poly (dI-dC), 3µg nuclear
extract, in 10 mM Tris-HCl [pH 8.0], 50 mM KCl, 5 mM MgCl2, 1
mM DTT, 2.5% (v/v) glycerol, 0.05% (v/v) NP-40, 0.3 mg/ml
BSA, 1 mM EDTA. After 30 min incubation at 37 °C, reactions
were loaded onto a non-denaturing 5% acrylamide gel. Biotin-
labeled DNA was visualized with Chemiluminiscent nucleic acid
detection kit (Pierce) following the manufacturer’s instructions.
Signals were quantify by densitometry by the Syngene Imaging
system (Syngene).
PCR analysis of the transposition process
HeLa cells (1x106) were transfected with 6 g of the self-
regulated pCA plasmid. After 72 hours of transfection, DNA
was extracted, digested by restriction enzymes cutting within
the transposon, PCR amplified and sequenced. PCR primers
were DIR172 (5’-GTTAGCTCACTCATTAGGCACC-3’) and
REV165 (5’-ATGTGCTGCAAGGCGATTAAG-3’). Nested PCR
primers were DIR123 (5’-CGTATGTTGTGTGGAATTGTG-3’)
and REV86 (5’-TAATACGACTCACTATAGGGC-3’). For nested
PCR, 1 µl of a dilution 1/100 from first PCR was amplified in 50
µl, run in agaraose gel 1%, DNA bands purified by Geneclean
(Qbiogene), sequenced at the Servei de Seqüenciació
(Universitat Autonoma, Barcelona) and BLAST analyzed. For
inverted PCR, pOX38 plasmid was extracted and recircularized
with T4 DNA ligase, further digested with Exonuclease I of E.
coli (NEB) and Lambda exonuclease (NEB) and purified.
Inverted PCR was performed using 250 ng of DNA in 50 µl of
volume. Primers were iPCR-I3R (5’-
AAGCAGGCATCGCCATGGGTCA-3’) and IPCR-I4D (5’-
AGCGCGGGGATCTCATGCTG-3’). Primers for following
nested PCR were N3R (5’-CCTGATGCTCTTCGTCCAGAT-3’)
and N4D (5’-GGAATAGGAACTAAGGAGGA-3’).
Results
Reassembling of the human mariner transposase
HSMAR2
We have regenerated the mariner transposon Hsmar2 by
assembling and modifying sequences from inactive Hsmar2
copies present in the human genome (Figure 1A). We detected
the existence of many dinucleotides with similar frequencies for
dinucleotide CG and dinucleotides CA or TG, and in all cases
the hypermutable CpG dinucleotide was reintroduced in the
sequence. Our sequence is very similar to the consensus
sequence obtained by Robertson and colleagues [7] since the
changes were introduced following the same criteria. However,
there are six differences between the two sequences, but only
one creates a change in an encoded amino acid: T to C at
position 259, causing the change Thr26 to Ile26 (Figure S1A).
The Hsmar2 transposon contains an open reading frame of
1053 bp, encoding a protein of 351 amino acids flanked by two
inverted terminal repeated (ITR) sequences of 31 and 33 bp
each, with an estimated molecular weight of 40.4 kDa.
HSMAR2 contains the hallmarks of mariner transposase
Figure 1.  Characterization of Hsmar2.  (A) Amino acid
sequence of the Hsmar2 transposase. The catalytic domain
DD34D is highlighted in grey. The DETW and the
LHHDNAPAH conserved motifs, which include respectively the
first and second D residue of the catalytic domain, are in red
and orange. The WVPKPL and the YSPDLAP motifs are
highlighted respectively in blue and purple. The amino acid
change compared to the consensus sequence U49974 is
highlighted in green. (B) Predicted secondary structure of
Hsmar2. The β-sheets are in red, and the α-helix in blue. The
HTH domain predicted by NPS and the NLS domain predicted
by PSORTII are indicated. (C) Values of the A/T prevalence of
the 5 bp-long consensus sequences flanking the Hsmar2
copies in the human genome and schematic representation
using the weblogo program (http://weblogo.berkeley.edu/).
doi: 10.1371/journal.pone.0073227.g001
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proteins, like the YSPDLAP motif and the catalytic triad DD34D
[23]. The three aspartic acid residues are located at positions D
160D254D289, and the first residue is part of the DETW motif
conserved in the irritans subfamily. {Baba, 2005 #67}{Bell,
2007 #85} The secondary structure of the consensus HSMAR2
was predicted by Network Protein Sequence Analysis using the
DSC [24] and PHD [25] methods and confirmed by the Predict
Protein program [26] (Figure 1B). A putative HTH motif (helix-
turn-helix), typically found in DNA transposases and involved in
DNA binding, was predicted at position 88 but the score (0.58)
was not significant. In addition, the program NUCDISC
PSORTII [27] detected a bipartite Nuclear Localization Signal
(NLS) at position 39, with a basic residue content of 16.5% and
a score of 0.02. The ITRs size and non-identical sequences are
characteristic of the mariner elements [28]. Nevertheless, due
to our analysis, we introduced two changes in the ITR-3'
compared to Hsmar2 U49974: one T-insertion at position 1277
and a C to T substitution at position 1280 (Figure S1B).
Moreover, we identified a 5 bp consensus sequence flanking
Hsmar2 elements, including the canonical TA dinucleotide
(Figure 1C). We reasoned that these nucleotides may
contribute to the recognition of ITRs in the transposition
process and we therefore introduced them in the Hsmar2
transposon.
Since transposons can be mobilized in trans by the
transposases if they contain cognate ITRs, the HSMAR2
transposase gene was separated and replaced by other genes.
In order to facilitate the characterization of HSMAR2 in cells in
culture, a fusion protein between the C-terminus of GFP and
HSMAR2, was generated and introduced into an adenovirus
vector and Hela and HEK293 cells were subsequently infected.
In addition, a polyclonal antibody (AbHsmar2-1001) against the
N-terminal region of Hsmar2 was also generated and allowed
the specific recognition and immunoprecipitation of the
transposase (Figure S2A, S2B). Interestingly, the
AbHsmar2-1001 antibody did not detect the transposase in
non-transfected HeLa cells indicating that natural expression of
HSMAR2 was null or very low in this cell line.
Sub cellular localization of HSMAR2 and effect of its
expression in the cell viability
To study the subcellular localization of the HSMAR2
transposase, different mammalian cell lines were infected with
Ad/GPF-HSMAR2 and Ad5/RFP (as control). As observed in
Figure 2 the fluorescence associated with the GFP-HSMAR2
fusion protein was mainly observed in the nucleus of cells,
which is the expected localization for a protein that interacts
with DNA.
In initial experiments, HeLa cells transduced with HSMAR2
showed changes in their morphology, had granules in the
cytoplasm and detached from the plates preventing the
progression of the experiment. To test whether overexpression
of HSMAR2 was cytotoxic, we generated a plasmid carrying
the Zeocin resistance gene (pZeo/CMV-HSMAR2) and the
coding region of the HSMAR2 transposase. Transfected cells
were selected for 15 days in order to measure the survival
rates of HeLa cells expressing HSMAR2 by quantifying their
capacity to generate Zeo-resistant colonies. As seen in Figure
3A and 3B, the number of Zeo-resistant colonies after
transfection with the pZeo/CMV-HSMAR2 was 5-6 times lower
than using a control plasmid without the HSMAR2 gene. To
monitor whether it was possible to detect cytotoxicity due to
overexpression of HSMAR2 early after transfection, HeLa cells
were transfected with increasing doses of plasmid pGFP-
HSMAR2 and analyzed by flow cytometry. As seen in Figure
3C, at 24 hours post-transfection the percentage of living cells
expressing GFP is similar for both vectors. However, the
percentage of living cells expressing pGFP-HSMAR2
decreased over time (45% to 26%), while transfection with the
control GFP-plasmid increased the percentage from 52% to
79% (as GFP accumulated and was better detected over time),
indicating that the cytotoxicity observed at 72 hours must be
associated with the expression of HSMAR2.
To better study the mechanism involved in the HSMAR2-
induced toxicity, HeLa cells were infected with increasing MOI
of Ad5/GFP-HSMAR2. As expected, a gradual decline in the
number of adherent cells and drastic changes in cell
morphology were observed when increasing the amount of
Figure 2.  Subcellular localization of the HSMAR2.  Different
cell lines were infected (MOI = 30) with Ad/GFP-HSMAR2 and
Ad/RFP. At 48h post-transfection cells were Hoechst stained
and further analyzed by confocal microscopy.
doi: 10.1371/journal.pone.0073227.g002
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Figure 3.  Overexpression of HSMAR2.  induces cytotoxity in HeLa cells. (A) HeLa cells were transfected with pZeo/CMV-
HSMAR2 and the control plasmid pcDNA3-Zeo and selected by Zeocin resistance for 15 days. Cell clones were counted after
crystal violet staining. (B) Number of resistant Zeo-colonies per plate. The results come from two independent experiments. The
asterisk indicates significant differences compared to control by Student’s t-test (p = 1,7E-07). (C) HSMAR2 induces cytotoxity at
short time periods. The graphs represent the percentage of living cells (propidium iodide negative) expressing GFP- HSMAR2, for
each dose of plasmid used. The results come from two independent experiments. (D) Images correspond to 72 hours post-infection
of HeLa cells at increasing MOIs of Ad5/GFP-HSMAR2 (MOI 3, 5, 10 and 15) compared to infection of control Ad5/GFP (MOI 25
and 50). Each condition is visualized by both, fluorescence and bright field microscopy. (E) Western blot of protein extracts from
HeLa cells transfected with the self-regulated expression plasmid pCA, using the AbHsmar2-1001 and anti-GFP antibodies. Same
amount of total protein extracts were use in both conditions. Negative control: non-transfected HeLa cells. (F) Overexpression of the
self-regulated HSMAR2 construct. The images correspond to the expression observed after 72 hours in HeLa cells transfected with
increasing amounts of plasmid pCA (0.25, 0.5, 1, 1.5, 2, 3, 5, 12µg for 1.5 E + 06 cells).
doi: 10.1371/journal.pone.0073227.g003
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infecting adenovirus (Figure 3D). These adverse effects were
seen even at low MOIs (MOI = 5). However, when infecting
with the control Ad/GFP vector, cytotoxicity was not observed
even at MOIs 10 times higher (MOI=50). Finally, to test
whether there is any relationship between the nuclear
localization of the HSMAR2 and cytotoxicity, we infected
several mammalian cell lines (HeLa, DKZeo and COS7) with
Ad/GFP-HSMAR2 at MOI=50 and analyzed cell viability 72
hours later. However, except in HeLa cells, there was no
obvious toxicity (data not shown). Therefore, though nuclear
localization of GFP-HSMAR2 may be required for cytotoxicity, it
is not sufficient by itself, and other issues (i.e. the presence of
specific host factors) may be involved in the process.
Self-regulation of HSMAR2 expression
Due to the cytotoxicity caused by HSMAR2 overexpression
over time, we generated a negative self-regulated expression
cassette, where the HSMAR2 expression decreases as the
effect of its own transposase action, thus avoiding the
prolonged expression of HSMAR2. To this end, we constructed
the plasmid pCA, where the ITR sequences flanked both, a
GFP expression cassette, as well as the CMV promoter driving
the expression of HSMAR2, while the transposase gene was
inserted outside of the ITRs. HeLa cells were transfected with
pCA and 48 hours post-transfection, both the GFP gene within
the transposon, and the HSMAR2 transposase were efficiently
expressed (Figure 3E). Interestingly, when HeLa cells were
transfected with increasing amounts of plasmid, cell viability
was similar in all conditions even when high levels pCA were
used (Figure 3F) indicating that the self-regulated expression of
HSMAR2 prevents the cytotoxic effects associated with its
continuous expression.
HSMAR2 is able to bind specifically its own ITRs
The first step of the transposition reaction is the binding of
the transposase to the terminal ends of the transposon. To
determine whether HSMAR2 is able to recognize and bind its
own ITRs specifically, HeLa cells were infected with Ad/GFP-
HSMAR2 and analyzed by mobility shift assay (EMSA) using
oligonucleotides from the 5’-ITR labeled with biotin. As seen in
Figure 4A, a retarded band is detected only when nuclear
extracts were obtained from cells infected with the Ad/GFP-
HSMAR2 vector. The retarded band was not observed in any
of the controls, including in HeLa cells infected with Ad/CMV-
GFP. Next, competitive EMSAs were performed to determine
the level of specificity of the interaction between HSMAR2 and
ITR, and designed following a double strategy: competition with
non-labelled ITR-oligonucleotides, and competition with
randomized ITR-oligonucleotides (Figure 4B). Interestingly,
increasing amounts of the specific competitor gradually
inhibited the binding of HSMAR2 to the ITR sequence up to
more than 80%. However, the binding of HSMAR2 to the ITR
was not altered by the presence or excess of non-specific
competitor with a randomized sequence. Therefore, HSMAR2
is capable of forming nucleoproteic complexes with its own
ITRs and this interaction is sequence specific. Finally, to
analyze whether the HSMAR2 transposase is also able to
recognize other transposons of the Tc1/mariner superfamily as
for example Sleeping Beauty, HeLa cells were cotransfected
with the HSMAR2 transposase plus the the Sleeping Beauty
transposon (pIR-neo), which contains their specific inverted
repeats (IR) flanking the neomycin resistance gene; or with the
Sleeping Beauty transposase together with the HSMAR2
transposon pITR (CG+5T)-neo. As expected, no cross-
recognition between the two transposases was observed
(Figure S3).
HSMAR2 excision and footprint analysis
To study the excision step we analyzed the donor molecule
because after transposition and the subsequent DNA repair
process, the donor plasmid is smaller and can be detected with
external primers flanking the ITRs. To this end, HeLa cells
were transfected with the self-regulated pCA plasmid. After 72
hours of transfection, low molecular DNA was extracted by the
Hirt method and digested by restriction enzymes cutting within
the transposon, and finally PCR amplified, cloned and
sequenced. If transposon excision was accurate and canonical,
all sequences should be identical. However, the HSMAR2
transposase did not excise the transposon perfectly, but
utilized cutting sites before and after the ITRs (Figure 5A).
Thus, for the 5’-ITR, two major excision sites were detected at
positions -15 and -16, while for the 3’-ITR the cutting reaction
showed more variability, with deletions and even cuts inside
the expression cassette between the ITRs, suggesting that
though the regenerated HSMAR2 transposase has nicking
activity, its catalitic domain must not be fully functional.
Analysis of the transposition process in prokaryotes
mediated by HSMAR2
The transposition assay for conjugation (mating-out assay)
measures in bacteria the frequency of transposition of a
Kanamycin resistance gene, flanked by ITRs, to an F plasmid.
Based on previous experiments in Himar1 by one of us (DJL)
[29], where overexpression of HIMAR1 is associated to self-
inhibition, the HSMAR2 motif WVPKPL was mutagenized to the
canonical motif WVPREL to thus generate HSMAR2-DL, and
therefore facilitate the generation of hyperactive constructs. In
addition, since overexpression of HIMAR1 is also associated
with cytotoxicity [30], we cloned, both the coding sequence for
the consensus HSMAR2 and the mutagenized HSMAR2-DL
under the control of the arabinose inducible araBAD promoter
(Figure S4).
In order to check whether HSMAR2 has also a preference for
certain sequences at the ends of the ITRs, we also generated
two constructs carrying a kanamycin resistance gene, where
the flanking ITRs show slight differences in their sequences, as
the outer two nucleotides were changed from CG to TT. As
seen in Figure 5B both, HSMAR2 transposases (HSMAR2 and
HSMAR2-DL) are able to transpose in E. coli at similar levels,
suggesting that the WVPKPL motif of HSMAR2 is probably
under natural selection to produce inhibition by overexpression,
which it would open the door to generate hyperactive
constructs of HSMAR2. We also observed better efficiency
when the transposon contained the CG dinucleotide at the end,
instead of the TT dinucleotide. To analyze the integration sites
to the target plasmid, DNA of the F plasmid was extracted from
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independent colonies, digested with restriction enzymes,
recirculated, analyzed by inverted PCR followed by a nested
PCR (Figure 5C), and sequenced. Interestingly, we detected
several independent events within the same gene in more than
one sample, indicating that, at least in the target plasmid
pOX38, HSMAR2 shows preference for some regions (Figure
5D). However, as it happened for the excision process, no
events involving the TA dinucleotide were observed.
Analysis of the transposition process in eukaryotes
mediated by HSMAR2
HeLa cells were cotransfected with the pITR-neo and pGFP-
HSMAR2 plasmids system and grown in selective conditions in
Figure 4.  Binding of the HSMAR2.  transposase to its ITR sequences. (A) EMSA assay. Detection of the binding of Hsmar2 to
the ITR sequence. Double-stranded oligonucleotides with the ITR sequence biotin-labeled were incubated with nuclear extracts
from HeLa cells infected with adenovirus Ad/EGFP-HSMAR2 (third lane). The retarded band is marked with an arrow. Controls are:
no incubation with nuclear extracts (first lane), with extracts from non-infected HeLa cells (second lane), and incubation with HeLa
cells infected with an adenovirus not expressing HSMAR2. (B) Competitive EMSA using nuclear extracts of HeLa cells infected with
Ad/GFP-HSMAR2. The major retarded band is marked with an arrow. Increasing amounts (1, 5, 15 and 50 nM) of a biotin-labeled
non-specific competitor (first four lanes) or of unlabeled duplex oligonucleotides of the 5’-ITR of Hsmar2 (last four lanes) were used.
The sixth lane shows the result of the binding reaction using no competitor. (C) Graph based on the intensity of the bands delayed,
from (B). Relative densitometry units refers to the direct quantification of the band signal by densitometry.
doi: 10.1371/journal.pone.0073227.g004
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Figure 5.  Analysis of the excision and transposition processes.  (A) Excision sites for the HSMAR2 transposase. Non-circled
numbers correspond to the clone numbers, while encircled numbers correspond to the cleavage sites. (B) Transposition frequencies
obtained with the mating-out assay (C) Amplification of the regions flanking the integration points. Gel bands (boxed) were cut and
sequenced. DNA samples from the F plasmid from independent colonies of the mating-out (NalR + KanR + GentR) assays. 1: TT-
clone, 2: TT-clone, 3: CG-clone, 4: CG-clone, 5: CG-clone. (D) Localization of the integration sites of the transposon ITR-KanR into
the target plasmid pOX38. It shows the site of transposon insertion by analyzing the sequence obtained by BLAST. (E) Number of
G418-resistant colonies after transposition in HeLa cells. The values correspond to the average of the neomycin-resistant clones of
four independent experiments with n=3 per condition. It also shows the same results into two separate graphs according to whether
the diameter of the cell clone if less than or equal to 1mm or is greater than 1mm. The asterisks indicate significant differences (the
Student’s t-test, *p < 0,01; **p<0,001). Negative control (pCIneo) corresponds to a cotransfection of the Hsmar2 transposase with a
plasmid carrying the Neo cassette but without the ITRs. In all cases, transfection conditions were 6 µg of plasmid per million cells.
doi: 10.1371/journal.pone.0073227.g005
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the presence of G418 for at least two weeks, until individual
clones appeared. To evaluate the non-specific integration, a
control plasmid (pCI-neo) without the ITR sequences was
used. Moreover, we also used a new ITR-construct carrying
one thymidine less in the 3’-ITR sequence (construct CG+4T)
to mimic the 3’-ITR of the consensus U49974 sequence of
Hsmar2 (Table S1) and thus study the effect of this sequence
variation since the Hsmar2 sequence has 5T within the 3’-ITR
(CG+5T). As seen in Figure 5E a significantly higher number of
neomycin-resistant clones is observed when both, the
HSMAR2 transposase and the transposon are co-transfected.
We also observed that HSMAR2 seems to show preference for
the ITRs with the CG+5T sequence, as the number of clones is
higher when the cells are transfected with this transposon.
These results suggest that the HSMAR2 protein may have
transposase activity, and second, that the transposon ITR-neo
contains in cis the required sequences for transposition, with
an activity activity similar to that of other elements as SB11,
piggybac or Tol2 in HeLa cells [31]. Some authors have
hypothesized that the size of the clones may be used as an
indication of the transposition, because after 2 weeks of
selection, colonies smaller than 1 mm are difficult to expand in
the presence of the antibiotic and are considered to be non-
specific clones or to have unstable inserts [32]. In this regard,
when only colonies bigger than 1 mm are taken into account,
the transposition efficiency is significantly higher (2-3 times) in
plasmids containing ITR-transposons than in control plasmid
(p=0,0003 for pITR CG+5T; p=0,001 for pITR CG+4T), while
when taking into account smaller colonies, the profiles are
inverted and the efficiency is reduced by 30% to 50% (Figure
5E).
Discussion
In order to increase the applications of Tc1/mariner
transposons as genetic tools it is desirable to obtain and
characterize new transposables elements with different
properties. To this end, we have regenerated the human
mariner transposase HSMAR2 and characterized its activity,
and have observed toxicity by overexpression, which led us to
generate a system for the self-regulated expression of the
transposase. The transposition process of DNA fragments
follows a cut and paste mechanism consisting of several steps
that include binding of the transposase sequences to the
terminal ITRs to form a synaptic complex, the excision of the
transposon from the donor molecule, and the integration into a
new site in the genome. For the HSMAR2 transposase we
have been able to detect and characterize each of the
successive steps of the transposition process: the capacity of
HSMAR2 to recognize and bind specifically to its terminal
repeat sequences, as well as the excision of the transposon,
documented by the footprints left in the donor molecule.
After regenerating a copy of the human mariner HSMAR2 we
demonstrated that it can be stably expressed in human cells,
and that we were able to detect it by generating specific
antibodies. Moreover, the fluorescence associated with the
expression of GFP-HSMAR2 was localized primarily into the
nucleus of HeLa cells, which is the expected localization for a
protein that interacts with DNA and suggests that HSMAR2
must be actively transported to the nucleus and therefore it
must have a functional NLS in its sequence. In fact, since
proteins of more than 60 kDa require selective transport
mechanisms to pass through the nuclear pore complex [33]
GFP-HSMAR2 (molecular weight of about 70 kDa) must be
actively imported into the nucleus after being synthesized in the
cytoplasm, suggesting that it should have a functional NLS in
its sequence. In this regard, most of the active transposases
have nuclear localization signals. For example, the SETMAR
transposase, which has a partial transposase activity, is
localized in the nucleus of HEK293 cells and the nuclear
extracts can be used in in vitro assays [34]. However, in the
absence of structural information on HSMAR2, we can only
infer the presence of certain structural motifs. Thus, the
predicted secondary structure of HSMAR2 by some
bioinformatics programs suggests the presence of a bipartite
NLS, though it does not seem to be a classic NLS signal.
However, other programs did not detect any NLS sequence
and in fact, the majority of programs identified HSMAR2 as a
cytoplasmic protein.
Interestingly, overexpression of HSMAR2 in HeLa cells is
cytotoxic. What it governs this effect is not known, although it
may be associated with its nuclear localization. Thus, it is likely
that due to the existence of inactive copies of the transposase
HSMAR2 the human genome, its overexpression in human
cells may cause either the generation of nicks into the DNA or
uncontrolled movements of these inactive copies, triggering the
activation of cellular apoptotic pathways in a process similar to
that observed in the overexpression of other proteins with
binding and cutting capacity of DNA molecules, such as the
Cre recombinase, which is associated with cell toxicity probably
due to the existence of cryptic binding sites for the
recombinase or pseudo loxP present at the genomes of
mammals [35]. Despite these results, localization into the
nucleus is not sufficient to cause cytotoxicity and other issues
(i.e. the presence of specific host factors) might have a role.
The ability of mariner elements to act with relative
independence of species-specific factors is exemplified by the
diverse range of hosts, and could help explain their ability to
transfer horizontally to new hosts. For example, the Sleeping
Beauty transposase is active in most mammalian cells but the
frequency of transposition varies between cell lines as well as
in vivo, being higher in murine germ cells that in murine
embryonic stem cells, suggesting the existence of mechanisms
regulating their transposition. However, it cannot be excluded
that factors encoded by the host cell in some organisms are
necessary for transposition in vivo because the absence of
these factors could explain why transposition is not always
detected and why it has so much variability [31,36]. Moreover,
it has been reported that Himar1 shows differences in the
frequency of transposition between different clones of HeLa
cells, which could be due to differences between levels of a
cellular factor that modulates the efficiency of transposase [29].
As expected, the HSMAR2 transposase binds specifically to
its terminal sequences. In addition, there is no cross-
recognition between the Sleeping Beauty and HSMAR2
transposases. Consistently, it has been reported that the MAR
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region of the Hsmar1-derived element SETMAR does not
recognize the ITR-Hsmar2 sequences [37]. After the
transposase: ITR interaction, the double strand breaks
generated during the excision of the transposon are likely
repaired by a mechanism of non-homologous end joining
(NHEJ) [36,38]. The double strand breaks stimulate repair
processes in mammals by homology directed repair
mechanims, and so it has been proposed that non-canonical
footprints could be due to disruption of these processes,
particularly for interruptions in the repair mechanisms of the
homologous recombination of double-stranded DNA cuts
which, together with binding processes of the DNA ends, would
result in microhomologies [39]. In this regard, after the excision
process, although some canonical events produced by NHEJ
are expected, the footprints left by HSMAR2 were not
canonical, especially at the 3’-ITR where more variability was
observed. Interestingly, similar results have been described for
other transposases, with footprints of different sizes including
non-canonical footprints like gaps and insertions. For example,
the SETMAR protein is only capable of cutting the 5'-end, by
generating footprints associated with small extensions,
deletions and micro-homologies at the excision sites [40].
Similarly, the Sleeping Beauty transposase showed variable
results depending on the cell type used: mostly canonical
footprints obtained in zebrafish, and hepatocytes and
embryonic stem cells from mice [41,42], while non-canonical
footprints are found in HeLa cells in culture [41] and in haploid
espermatids in mouse [36]. However, despite the ability of the
transposase itself to perform cut and paste transposition from
TA parental sites to TA target sites, this phenomenon likely
reflects the different availability of NHEJ repair factors in
different cell lines either because the host repairs the excision
sites with different efficiency, and/or homologue-dependent
repair pathways operate more dominantly in certain cells than
NHEJ.
Until now, the strategies to generate improved versions of
tranposases have been based primarily on random
mutagenesis with genetic selection and subsequent functional
analysis of each mutated version. Thus, the Himar1
transposase was mutagenized and hyperactive constructs
selected, such as the C9 version which is currently used as a
genetic tool [30]. This work also studied the effects of dominant
negative inhibition of mutated variants of Himar1, showing that
the highly conserved domain WVP(R/H) EL of mariner
elements generated hyperactive mutants in papillation assays
when the W, V, P and E amino acids were mutated to alanine
[43]. Moreover, in the Mos1 element this motif is involved in
selecting the integration site, since mutations in this site permit
a relaxation of the specificity, including integrations also in the
dinucleotide CG [44]. Interestingly, despite HSMAR2 does not
have the consensus WVP(R/H) EL motif, the values obtained in
the mating-out assay are similar to the HSMAR2 mutant
construct carrying it (HSMAR2-DL) suggesting that the
WVPKPL motif of HSMAR2 is probably under natural selection
to produce inhibition by overexpression, which it would open
the door to generate hyperactive constructs of HSMAR2. In
addition, the frequency was clearly higher when the transposon
was flanked by the ITRs ending with the canonical GC
dinucleotide. More important, the values were similar to those
found for IS elements (of the itm superfamily) [45] and Tn5 and
Tn7 elements [46,47], or for Himar1 in similar mating-out
assays [30]. However, although HSMAR2 can be transported
to the nucleus, can specifically bind to Hsmar2-ITRs in vitro
(thus the DNA-binding helices and the NLS of the transposase
version are functional), and transposes Hsmar2-ITR flanked
sequences preferently to specific target regions, neither the
excision nor the transposition processes were canonical in both
bacteria and human cells, and therefore, despite the catalytic
domain has nicking activity is not able to cut and paste the
transposon precisely at the TA dinucleotides. Due to it, future
studies to reconstruct and optimize the catalytic domain of
HSMAR2 must be addressed.
In summary, we observe that the sub-cellular localization of
HSMAR2 is dependent on the host cell type and that HSMAR2
is cytotoxic when overexpressed in HeLa cells. T herefore the
use of self-regulated cassette makes the HSMAR2 an
interesting tool for genetic studies, while the development of
specific antibodies may facilitate the study of the Hsmar2
association to hotspots for homologous recombination involved
in human genetic disorders as Charcot–Marie–Tooth, Prader-
Willi, Angelman, and Williams syndromes.
Supporting Information
Figure S1.  Sequence of the transposable element Hsmar2
reconstructed by our group. (A) Sequence of Hsmar2. ITRs
are shown in green, with the sequence 5'-CGAGGG-3' marked
in yellow. In black are non-translated regions (UTR) underlined,
and in the blue region coding for the transposase protein (CDS,
coding sequence), with START and STOP codons highlighted
in capitals. In orange are the changes compared with the
consensus sequence published by Robertson (GenBank
Accession No. U49974, Protein ID AAC52011.1 UniProt entry
Q13539) (Robertson HM, Martos R, 1997, Gene 205:
219-228). (B) Two changes were introduced in the ITR-3'
compared with Hsmar2 U49974: one T-insertion at position
1277 and a C to T substitution at position 1280.
(TIF)
Figure S2.  (A) Western blot using specific antibodies
against Hsmar2 and against GFP. HeLa cells were
transfected with pGFP-Hsmar2, pKS-RSV/GFP or non-
transfected. (B) Specific Immunoprecipitation of Hsmar2 and
western blotted using an antibody against GFP.
(TIF)
Figure S3.  Absence of cross-recognition between the
transposases Hsmar2 and Sleeping Beauty (SB).
Cotransfection in HeLa cells with the indicated combinations of
plasmids and subsequent selection for two weeks in the
presence of G-418. Cell clones were visualized after crystal
violet staining.
(TIF)
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Figure S4.  Analysis of the excision and transposition
processes. Detection of inducible Hsmar2 expression in E. coli
with increasing concentrations of arabinose (0 to 0.2%). Protein
extracts from bacterial cultures, previously induced with
increasing concentrations of arabinose, showed a band of the
expected size of Hsmar2 in denaturing polyacrylamide gels
Detection with antibody specific AbHsmar2-1001.
(TIF)
Table S1.  Sequences of the ITRs Hsmar2 used in the
transposition assay in HeLa cells. CG or TT dinucleotides
are in bold, and the 4T or 5T sequences are underlined.
(TIF)
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